Galantamine Provides Broad Benefits in Patients With ‘advanced Moderate’ Alzheimer's Disease (mmse ≤12) for up to Six Months
Year: 2002
Type: article
Authors: DG Wilkinson, C Hock, M Farlow, B Van Baelen, S Schwalen
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4367473664
